ingineeon
Our teams
Next-Generation Immunotherapeutics
Active immunomodulation is one of the most promising approaches in modern precision medicine. We at ingineeon develop first-in-class cytokine-based immunotherapeutics with breakthrough potential in infectious diseases, immuno-oncology and autoimmunity.
Ingineeon is a Munich-based biotech company. In a defined path forward, we will soon bring our first-in-class immunotherapeutics to the clinics for the benefit of patients in need.
Founded 24.09.2025.
Vision of ingineeon:
"We are very excited to be part of the MAxL Incubator. Its vibrant startup ecosystem and strong community create a perfect environment to develop ingineeon to a leading, innovative biotech company with headquarters ideally located South of Munich."
The team of ingineeon:
- Daniel Horn-Ghetko, Co-Founder - LinkedIn profile
- Isabel Aschenbrenner, Co-Founder - LinkedIn profile
- Dr. Julia Behnke eMBA, Co-Founder - LinkedIn profile
- Prof. Dr. Matthias Feige, Co-Founder